ProCE Banner Activity

SEAM-RA: Maintenance of Remission Better After Withdrawal of Methotrexate Than Withdrawal of Etanercept

Slideset Download
Conference Coverage
At Week 48, SDAI remission maintained in 49.5% of patients receiving etanercept monotherapy vs 28.7% of patients receiving methotrexate monotherapy.

Released: November 12, 2020

Expiration: November 11, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gilead Sciences, Inc.

Sanofi Genzyme Corp